RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
QuiaPEG Pharmaceuticals Holding Stock

QuiaPEG Pharmaceuticals Holding Debt 2024

QuiaPEG Pharmaceuticals Holding Debt

20.51 SEK

Ticker

QUIA.ST

ISIN

SE0001384850

WKN

A0X94X

In 2024, QuiaPEG Pharmaceuticals Holding's total debt was 20.51 SEK, a 58.31% change from the 12.96 SEK total debt recorded in the previous year.

QuiaPEG Pharmaceuticals Holding Aktienanalyse

What does QuiaPEG Pharmaceuticals Holding do?

QuiaPEG Pharmaceuticals Holding AB is a Swedish company specialized in the research and development of medications for various diseases. The company was founded in Stockholm in 2009 and has since become a leading biotechnology company. QuiaPEG Pharmaceuticals aims to accelerate the discovery and development of medications to provide more effective therapies to patients worldwide. The company's business model is based on partnerships with large global pharmaceutical and biotech companies to develop and market medications. The company operates in multiple areas, including the research and development of cancer therapies, infectious diseases, autoimmune diseases, and neurodegenerative diseases. QuiaPEG Pharmaceuticals focuses on treating serious diseases that currently lack effective medications or have inadequate treatment options. The company has a pipeline of products in development, including new cancer therapies that target cancer cells without affecting healthy cells. Another product currently in development is a new medication for treating autoimmune diseases, addressing the underlying disease rather than just relieving symptoms. QuiaPEG Pharmaceuticals also specializes in developing medications for treating infectious diseases such as hepatitis B and C and HIV, serious diseases that have not yet been fully cured. The company is actively researching medications that can block the infection process or prevent virus spread in the body. Another important area of focus for the company is research on neurodegenerative diseases such as Alzheimer's and Parkinson's. QuiaPEG Pharmaceuticals is working on new compounds that can help halt disease progression and alleviate symptoms. The company has established extensive research collaborations with state-of-the-art laboratories and research centers worldwide to accelerate development and research. QuiaPEG Pharmaceuticals has an effective analysis platform for identifying potential drug candidates, significantly expediting the drug development process. In summary, QuiaPEG Pharmaceuticals Holding AB is a company focused on researching and developing medications to treat serious diseases. The company has a diverse pipeline of developments and collaborates extensively with leading research and development centers worldwide. QuiaPEG Pharmaceuticals aims to provide effective therapies to patients and make a significant contribution to the field of biotechnology. QuiaPEG Pharmaceuticals Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding QuiaPEG Pharmaceuticals Holding's Debt Structure

QuiaPEG Pharmaceuticals Holding's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing QuiaPEG Pharmaceuticals Holding's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to QuiaPEG Pharmaceuticals Holding’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in QuiaPEG Pharmaceuticals Holding’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about QuiaPEG Pharmaceuticals Holding stock

What is the debt of QuiaPEG Pharmaceuticals Holding this year?

QuiaPEG Pharmaceuticals Holding has a debt level of 20.51 SEK this year.

What was the debt of QuiaPEG Pharmaceuticals Holding compared to the previous year?

The debt of QuiaPEG Pharmaceuticals Holding has increased by 58.31% compared to the previous year increased.

What are the consequences of high debt for investors in QuiaPEG Pharmaceuticals Holding?

High debt can pose a risk for investors of QuiaPEG Pharmaceuticals Holding, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of QuiaPEG Pharmaceuticals Holding?

Low debt means that QuiaPEG Pharmaceuticals Holding has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from QuiaPEG Pharmaceuticals Holding affect the company?

An increase in debt of QuiaPEG Pharmaceuticals Holding can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of QuiaPEG Pharmaceuticals Holding affect the company?

A reduction in debt of QuiaPEG Pharmaceuticals Holding can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of QuiaPEG Pharmaceuticals Holding?

Some factors that can influence the debt of QuiaPEG Pharmaceuticals Holding include investments, acquisitions, operating costs, and revenue development.

Why are the debts of QuiaPEG Pharmaceuticals Holding so important for investors?

The debts of QuiaPEG Pharmaceuticals Holding are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can QuiaPEG Pharmaceuticals Holding take to change the debt?

To change the debt, QuiaPEG Pharmaceuticals Holding can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does QuiaPEG Pharmaceuticals Holding pay?

Over the past 12 months, QuiaPEG Pharmaceuticals Holding paid a dividend of 5.15 SEK . This corresponds to a dividend yield of about 28,600 %. For the coming 12 months, QuiaPEG Pharmaceuticals Holding is expected to pay a dividend of 0 SEK.

What is the dividend yield of QuiaPEG Pharmaceuticals Holding?

The current dividend yield of QuiaPEG Pharmaceuticals Holding is 28,600 %.

When does QuiaPEG Pharmaceuticals Holding pay dividends?

QuiaPEG Pharmaceuticals Holding pays a quarterly dividend. This is distributed in the months of June, July, April, April.

How secure is the dividend of QuiaPEG Pharmaceuticals Holding?

QuiaPEG Pharmaceuticals Holding paid dividends every year for the past 0 years.

What is the dividend of QuiaPEG Pharmaceuticals Holding?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is QuiaPEG Pharmaceuticals Holding located?

QuiaPEG Pharmaceuticals Holding is assigned to the 'Health' sector.

Wann musste ich die Aktien von QuiaPEG Pharmaceuticals Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of QuiaPEG Pharmaceuticals Holding from 4/5/2017 amounting to 5.55 SEK, you needed to have the stock in your portfolio before the ex-date on 3/30/2017.

When did QuiaPEG Pharmaceuticals Holding pay the last dividend?

The last dividend was paid out on 4/5/2017.

What was the dividend of QuiaPEG Pharmaceuticals Holding in the year 2023?

In the year 2023, QuiaPEG Pharmaceuticals Holding distributed 0 SEK as dividends.

In which currency does QuiaPEG Pharmaceuticals Holding pay out the dividend?

The dividends of QuiaPEG Pharmaceuticals Holding are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von QuiaPEG Pharmaceuticals Holding

Our stock analysis for QuiaPEG Pharmaceuticals Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of QuiaPEG Pharmaceuticals Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.